The safety of OZEMPIC tablets (1.5 mg, 4 mg and 9 mg strengths) [see Dosage and Administration (2.2)] and RYBELSUS (3 mg, 7, mg and 14 mg strengths) [see Dosage and Administration (2.2)] has been established as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus based on adequate and well-controlled studies of RYBELSUS in adult patients with type 2 diabetes mellitus [see Clinical Pharmacology (12.3), Clinical Studies (14)]
It is not intended for human or veterinary use and is not approved for clinical, diagnostic, or therapeutic applications
GLP-1 receptor agonists are medications used primarily for type 2 diabetes and obesity management, working by mimicking natural GLP-1 hormone
Fatigue or dizziness Some users report feeling tired or lightheaded, particularly during the first few weeks
If you're doing badly from it, well, maybe you need to step back, talk with your healthcare professional and say, "Hey, I think this pro-oxidative therapy is not doing me justice because I'm actually feeling terrible